Insider Trading activities of Supernus Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Supernus Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Supernus Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Supernus Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is SUPN. The reporting company's CIK number is 1356576.
The total value of stock buying since 2005 is $83,026,170.
The total value of stock sales since 2005 is $36,778,746.
The total value of stock option exercises since 2005 is $2,523,500.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Supernus Pharmaceuticals Inc (SUPN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-09 0 $0 150,000 $7,073,955 175,000 $1,778,599
2017-08 0 $0 3,709 $167,754 0 $0
2017-07 0 $0 3,735 $167,701 0 $0
2017-06 0 $0 12,556 $513,334 0 $0
2017-05 0 $0 8,000 $281,706 0 $0
2017-04 0 $0 89,418 $2,902,143 50,000 $294,000
2016-09 0 $0 2,000 $50,000 0 $0
2016-07 0 $0 3,395 $74,690 0 $0
2016-04 0 $0 30,762 $507,234 0 $0
2015-12 0 $0 227,208 $3,312,461 0 $0
2015-11 0 $0 233,829 $3,851,620 16,179 $138,654
2015-07 0 $0 10,517 $211,669 0 $0
2015-06 0 $0 795,033 $13,198,819 0 $0
2015-03 0 $0 8,612 $103,444 8,612 $22,806
2015-01 0 $0 0 $0 55,500 $120,966
2014-12 0 $0 0 $0 2,188 $9,277
2013-12 0 $0 0 $0 2,187 $9,272
2013-08 0 $0 2,285 $18,759 0 $0
2013-03 53,000 $301,690 0 $0 0 $0
2013-02 0 $0 302,183 $2,281,120 25,000 $10,000
2012-12 7,000 $56,980 297,815 $2,062,337 50,313 $129,926
2012-06 0 $0 0 $0 25,000 $10,000
2012-05 16,533,500 $82,667,500 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Supernus Pharmaceuticals Inc insiders (SUPN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-09-08 Bhatt Padmanabh P. (Sr VP of IP, CSO) Sale 5,000 49.86 249,305
2017-09-08 Patrick Gregory S (VP, Chief Financial Officer) Sale 23,481 48.89 1,147,962
2017-09-08 Patrick Gregory S (VP, Chief Financial Officer) Option Ex 38,481 6.89 265,134
2017-09-07 Schwabe Stefan K.f. (Executive Vice President R&D) Sale 95,000 46.59 4,425,575
2017-09-07 Schwabe Stefan K.f. (Executive Vice President R&D) Option Ex 95,000 12.92 1,227,400
2017-09-07 Patrick Gregory S (VP, Chief Financial Officer) Sale 26,519 47.18 1,251,113
2017-09-07 Patrick Gregory S (VP, Chief Financial Officer) Option Ex 41,519 6.89 286,065
2017-08-16 Bhatt Padmanabh P. (Sr.VP of IP, CSO) Sale 3,709 45.23 167,754
2017-07-12 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 3,735 44.90 167,701
2017-06-23 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 2,556 44.90 114,774
2017-06-02 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 10,000 39.86 398,560
2017-05-26 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 2,500 35.90 89,757
2017-05-25 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 3,887 34.90 135,656
2017-05-24 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 1,613 34.90 56,293
2017-04-24 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 23,612 32.59 769,514
2017-04-24 Patrick Gregory S (VP, Chief Financial Officer) Sale 54,000 32.37 1,747,872
2017-04-24 Patrick Gregory S (VP, Chief Financial Officer) Option Ex 50,000 5.88 294,000
2016-09-16 Patrick Gregory S (VP, Chief Financial Officer) Sale 2,000 25.00 50,000
2016-07-14 Patrick Gregory S (VP, Chief Financial Officer) Sale 3,395 22.00 74,690
2016-04-11 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 30,762 16.49 507,234
2015-12-09 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 4,685 14.90 69,806
2015-12-08 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 9,553 14.90 142,339
2015-12-08 Barrett M James (Director) Sale 70,913 14.75 1,045,966
2015-12-07 Barrett M James (Director) Sale 71,067 14.38 1,022,227
2015-12-04 Barrett M James (Director) Sale 70,990 14.54 1,032,123
2015-11-25 Barrett M James (Director) Sale 16,179 16.35 264,494
2015-11-25 Barrett M James (Director) Option Ex 16,179 8.57 138,654
2015-11-18 Barrett M James (Director) Sale 43,000 16.50 709,543
2015-11-17 Barrett M James (Director) Sale 50,000 16.71 835,450
2015-11-16 Barrett M James (Director) Sale 19,650 16.13 317,033
2015-11-13 Barrett M James (Director) Sale 100,000 16.26 1,625,600
2015-11-04 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 5,000 19.90 99,500
2015-07-28 Schwabe Stefan K.f. (Executive Vice President R&D) Sale 2,350 21.20 49,831
2015-07-16 Patrick Gregory S (VP, Chief Financial Officer) Sale 6,217 20.00 124,340
2015-07-13 Schwabe Stefan K.f. (Executive Vice President R&D) Sale 1,950 19.23 37,498
2015-06-17 Baskett Forest (10% Owner) Sale 111,881 16.35 1,828,918
2015-06-17 Sandell Scott D (10% Owner) Sale 136,597 16.57 2,263,958
2015-06-17 Barrett M James (Director) Sale 111,881 16.35 1,828,918
2015-06-17 Barris Peter J (10% Owner) Sale 111,881 16.35 1,828,918
2015-06-16 Baskett Forest (10% Owner) Sale 111,464 16.85 1,878,056
2015-06-16 Sandell Scott D (10% Owner) Sale 95,437 16.93 1,615,748
2015-06-16 Barrett M James (Director) Sale 55,105 16.85 928,684
2015-06-16 Barris Peter J (10% Owner) Sale 55,105 16.85 928,684
2015-06-12 Schwabe Stefan K.f. (Executive Vice President R&D) Sale 2,051 18.27 37,471
2015-06-11 Schwabe Stefan K.f. (Executive Vice President R&D) Sale 3,631 16.38 59,464
2015-03-30 Bryan Jones W. (VP of Business Development) Sale 6,712 12.02 80,644
2015-03-30 Bryan Jones W. (VP of Business Development) Option Ex 6,712 2.56 17,182
2015-03-24 Bryan Jones W. (VP of Business Development) Sale 1,900 12.00 22,800
2015-03-24 Bryan Jones W. (VP of Business Development) Option Ex 1,900 2.96 5,624
2015-01-15 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Option Ex 37,500 2.56 96,000
2015-01-05 Bhatt Padmanabh P. (SR VP of IP, CSO) Option Ex 18,000 1.39 24,966
2014-12-16 Siebert John M (Director) Option Ex 2,188 4.24 9,277
2013-12-12 Siebert John M (Director) Option Ex 2,187 4.24 9,272
2013-08-19 Bhatt Padmanabh P. (Sr. VP of IP; CSO) Sale 2,285 8.21 18,759
2013-03-22 Bigham Michael (Director) Buy 15,000 5.65 84,795
2013-03-21 Siebert John M (Director) Buy 3,000 5.50 16,500
2013-03-20 Bigham Michael (Director) Buy 20,000 5.21 104,200
2013-03-15 Khattar Jack A. (President, CEO) Buy 10,000 6.15 61,460
2013-03-14 Patrick Gregory S (VP, Chief Financial Officer) Buy 5,000 6.95 34,735
2013-02-13 Orbimed Capital Gp Ii Llc Sale 150,000 7.58 1,136,400
2013-02-12 Orbimed Capital Gp Ii Llc Sale 152,183 7.52 1,144,720
2013-02-08 Bhatt Padmanabh P. (Sr. VP of IP; CSO) Option Ex 25,000 .40 10,000
2012-12-18 Orbimed Capital Gp Ii Llc Sale 100,000 7.08 707,700
2012-12-17 Orbimed Capital Gp Ii Llc Sale 197,815 6.85 1,354,637
2012-12-14 Siebert John M (Director) Option Ex 2,188 4.24 9,277
2012-12-12 Martin Tami Tillotson (VP of Regulatory Affairs) Option Ex 48,125 2.51 120,649
2012-12-04 Siebert John M (Director) Buy 7,000 8.14 56,980
2012-06-18 Bhatt Padmanabh P. (Sr. VP of IP; CSO) Option Ex 25,000 .40 10,000
2012-05-04 Nuerge William A. Buy 15,000 5.00 75,000
2012-05-04 Khattar Jack A. (President, CEO) Buy 5,000 5.00 25,000
2012-05-04 Martin Tami Tillotson (VP of Regulatory Affairs) Buy 2,500 5.00 12,500
2012-05-04 Hudson Frederick M. Buy 5,000 5.00 25,000
2012-05-04 Abingworth Management Ltd Buy 1,100,000 5.00 5,500,000
2012-05-04 Sheffery Michael B Buy 1,100,000 5.00 5,500,000
2012-05-04 Sandell Scott D (10% Owner) Buy 4,400,000 5.00 22,000,000
2012-05-04 Barrett M James (Director) Buy 4,400,000 5.00 22,000,000
2012-05-04 Patrick Gregory S (VP, Chief Financial Officer) Buy 3,000 5.00 15,000
2012-05-04 Siebert John M Buy 3,000 5.00 15,000
2012-05-04 Isaly Samuel D Buy 1,100,000 5.00 5,500,000
2012-05-04 Newhall Charles W Iii (Director) Buy 4,400,000 5.00 22,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of SUPN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Supernus Pharmaceuticals Inc (symbol SUPN, CIK number 1356576) see the Securities and Exchange Commission (SEC) website.